The coagulation defects of the blood of 30 patients after six months of dicumarol therapy have been studied. A preparation of brain or soybean phospholipids corrected the abnormal coagulation time and the thrombin generation test of patients on long-term dicumarol therapy. The deficiency in thromboplastin generation of these patients was not corrected.

This content is only available as a PDF.